Events, By Category and Date:
» Go to news mainHonouring Vanessa?
Posted by nte on
March 8, 2016
in
In Print
Doshi, P., Herder, M., & Jefferson, T. (8 Mar 2016). British Medical Journal blog.
"Health Canada seems to want to have it both ways: be seen as a regulator that serves the public interest through a progressive commitment to transparency, yet be trusted by industry to not publicly disclose any clinical trial data which it calls 'confidential business information.'" Read聽 ...
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of 鈥渙ld鈥� orphan drugs: considerations for Canada鈥檚 orphan drug policy
- Podcast or Perish: Episode 040: Fran莽oise Baylis
- Bioethicist Fran莽oise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World鈥憆enowned 起点传媒 bioethicist and battery pioneer win prestigious Killam Prize